{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:02:20Z","timestamp":1792839740421,"version":"4.5.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.coviro.2020.10.002","type":"journal-article","created":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T11:01:16Z","timestamp":1604228476000},"page":"36-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Immune system control of hepatitis C virus infection"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1469-2699","authenticated-orcid":false,"given":"Johnasha D","family":"Stuart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Salinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Grakoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2020.10.002_bib0005","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"Collaborators, G.B.D.C.o.D","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2020.10.002_bib0010","doi-asserted-by":"crossref","first-page":"11033","DOI":"10.3748\/wjg.v20.i32.11033","article-title":"Chronic hepatitis C and liver fibrosis","volume":"20","author":"Sebastiani","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.coviro.2020.10.002_bib0015","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jhep.2016.07.035","article-title":"The history of hepatitis C virus (HCV): basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control","volume":"65","author":"Bukh","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2020.10.002_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010023","article-title":"Hepatitis C virus: viral quasispecies and genotypes","volume":"19","author":"Tsukiyama-Kohara","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coviro.2020.10.002_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212734","article-title":"Differential prevalence and geographic distribution of hepatitis C virus genotypes in acute and chronic hepatitis C patients in Vietnam","volume":"14","author":"Le Ngoc","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2020.10.002_bib0030","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/hep.29050","article-title":"Laboratory of genetics and physiology 2 (LGP2) plays an essential role in hepatitis C virus infection-induced interferon responses","volume":"65","author":"Hei","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2020.10.002_bib0035","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1099\/jgv.0.000607","article-title":"Hepatitis C virus replicative double-stranded RNA is a potent interferon inducer that triggers interferon production through MDA5","volume":"97","author":"Du","year":"2016","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2020.10.002_bib0040","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hep.24763","article-title":"Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates","volume":"55","author":"Li","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2020.10.002_bib0045","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.virol.2019.01.024","article-title":"Activation of protein kinase R by hepatitis C virus RNA-dependent RNA polymerase","volume":"529","author":"Suzuki","year":"2019","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2020.10.002_bib0050","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.3389\/fimmu.2019.01586","article-title":"Comparative structure and function analysis of the RIG-I-like receptors: RIG-I and MDA5","volume":"10","author":"Brisse","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2020.10.002_sbref0055","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00725-19","article-title":"Hepatitis C virus infection is inhibited by a noncanonical antiviral signaling pathway targeted by NS3-NS4A","volume":"93","author":"Vazquez","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.10.002_bib0060","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00507-18","article-title":"Long noncoding RNA ITPRIP-1 positively regulates the innate immune response through promotion of oligomerization and activation of MDA5","volume":"92","author":"Xie","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.10.002_bib0065","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jmb.2010.04.059","article-title":"Regulation of PKR by HCV IRES RNA: importance of domain II and NS5A","volume":"400","author":"Toroney","year":"2010","journal-title":"J Mol Biol"},{"key":"10.1016\/j.coviro.2020.10.002_bib0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/cmi.2014.127","article-title":"Emerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infection","volume":"13","author":"Wong","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.coviro.2020.10.002_bib0075","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1038\/ncomms4872","article-title":"Emergent properties of the interferon-signalling network may underlie the success of hepatitis C treatment","volume":"5","author":"Padmanabhan","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2020.10.002_bib0080","doi-asserted-by":"crossref","first-page":"e00312","DOI":"10.1128\/JVI.00312-20","article-title":"Genotypic regulations of type I interferon induction pathways by the frame-shift (F) proteins of hepatitis C virus","volume":"94","author":"Lai","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.10.002_bib0085","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/infdis\/jix593","article-title":"Genetic variation at IFNL4 influences extrahepatic interferon-stimulated gene expression in chronic HCV patients","volume":"217","author":"Rosenberg","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2020.10.002_bib0090","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1189\/jlb.4RI0214-126R","article-title":"Immune control and failure in HCV infection--tipping the balance","volume":"96","author":"Dustin","year":"2014","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.coviro.2020.10.002_bib0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072583","article-title":"Interferon response in hepatitis C virus-infected hepatocytes: issues to consider in the era of direct-acting antivirals","volume":"21","author":"Sung","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coviro.2020.10.002_bib0100","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/hep.29877","article-title":"Impact of interferon lambda 4 genotype on interferon-stimulated gene expression during direct-acting antiviral therapy for hepatitis C","volume":"68","author":"Ramamurthy","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2020.10.002_bib0105","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.3748\/wjg.v23.i21.3815","article-title":"Prevalence of IFNL3 rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C","volume":"23","author":"Swiatek-Koscielna","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.coviro.2020.10.002_bib0110","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/hep.30699","article-title":"Interferon-induced transmembrane proteins mediate viral evasion in acute and chronic hepatitis C virus infection","volume":"70","author":"Wrensch","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2020.10.002_bib0115","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1038\/s41467-018-04685-9","article-title":"Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversity","volume":"9","author":"Strunz","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2020.10.002_bib0120","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9041030","article-title":"Immunomodulation of the natural killer cell phenotype and response during HCV infection","volume":"9","author":"Njiomegnie","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.coviro.2020.10.002_bib0125","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jcmgh.2015.09.004","article-title":"Natural killer cells in viral hepatitis","volume":"1","author":"Rehermann","year":"2015","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.coviro.2020.10.002_bib0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007935","article-title":"Individual liver plasmacytoid dendritic cells are capable of producing IFNalpha and multiple additional cytokines during chronic HCV infection","volume":"15","author":"Doyle","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2020.10.002_bib0135","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.4049\/jimmunol.177.10.6758","article-title":"Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection","volume":"177","author":"Dolganiuc","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2020.10.002_bib0140","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1002\/hep.26182","article-title":"Human blood dendritic cell antigen 3 (BDCA3)(+) dendritic cells are a potent producer of interferon-lambda in response to hepatitis C virus","volume":"57","author":"Yoshio","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2020.10.002_bib0145","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.molimm.2017.02.018","article-title":"The role of Kupffer cells in hepatic diseases","volume":"85","author":"Li","year":"2017","journal-title":"Mol Immunol"},{"key":"10.1016\/j.coviro.2020.10.002_bib0150","doi-asserted-by":"crossref","first-page":"11867","DOI":"10.1038\/s41598-017-11975-7","article-title":"Differential serum cytokine profiles in patients with chronic hepatitis B, C, and hepatocellular carcinoma","volume":"7","author":"Estevez","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.coviro.2020.10.002_bib0155","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.bbadis.2016.12.006","article-title":"The p7 viroporin of the hepatitis C virus contributes to liver inflammation by stimulating production of Interleukin-1beta","volume":"1863","author":"Farag","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.coviro.2020.10.002_sbref0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007593","article-title":"Modulation of calcium signaling pathway by hepatitis C virus core protein stimulates NLRP3 inflammasome activation","volume":"15","author":"Negash","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2020.10.002_bib0165","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268819001997","article-title":"Relationship of genetic polymorphisms in CTLA-4 and IL-18 with viral hepatitis: evidence from a meta-analysis","volume":"147","author":"Yu","year":"2019","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.coviro.2020.10.002_bib0170","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3389\/fimmu.2014.00266","article-title":"CD8(+) T-cell responses in acute hepatitis C virus infection","volume":"5","author":"Sung","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2020.10.002_bib0175","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1053\/j.gastro.2012.10.047","article-title":"Factors that determine the antiviral efficacy of HCV-specific CD8(+) T cells ex vivo","volume":"144","author":"Seigel","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coviro.2020.10.002_bib0180","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jhep.2012.02.030","article-title":"Low perforin expression of early differentiated HCV-specific CD8+ T cells limits their hepatotoxic potential","volume":"57","author":"Jo","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2020.10.002_bib0185","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1053\/j.gastro.2004.06.015","article-title":"High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection","volume":"127","author":"Lauer","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coviro.2020.10.002_bib0190","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1128\/JVI.01993-15","article-title":"Distinct escape pathway by hepatitis C virus genotype 1a from a dominant CD8+ T cell response by selection of altered epitope processing","volume":"90","author":"Walker","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.10.002_sbref0195","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1172\/JCI126277","article-title":"Hepatitis C virus-specific CD4+ T cell phenotype and function in different infection outcomes","volume":"130","author":"Chen","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coviro.2020.10.002_bib0200","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jhep.2019.06.025","article-title":"Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses","volume":"71","author":"Aregay","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2020.10.002_bib0205","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.immuni.2017.09.006","article-title":"Early transcriptional divergence marks virus-specific primary human CD8(+) T cells in chronic versus acute infection","volume":"47","author":"Wolski","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.coviro.2020.10.002_bib0210","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/ilar\/ilx028","article-title":"The chimpanzee model of viral hepatitis: advances in understanding the immune response and treatment of viral hepatitis","volume":"58","author":"Lanford","year":"2017","journal-title":"ILAR J"},{"key":"10.1016\/j.coviro.2020.10.002_bib0215","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1084\/jem.20030239","article-title":"Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection","volume":"197","author":"Shoukry","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.coviro.2020.10.002_bib0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006191","article-title":"Selective expansion of high functional avidity memory CD8 T cell clonotypes during hepatitis C virus reinfection and clearance","volume":"13","author":"Abdel-Hakeem","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2020.10.002_bib0225","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.immuni.2016.07.021","article-title":"T cell factor 1-expressing memory-like CD8(+) T cells sustain the immune response to chronic viral infections","volume":"45","author":"Utzschneider","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.coviro.2020.10.002_bib0230","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15050","article-title":"TCF1(+) hepatitis C virus-specific CD8(+) T cells are maintained after cessation of chronic antigen stimulation","volume":"8","author":"Wieland","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2020.10.002_sbref0235","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-019-1326-9","article-title":"TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection","volume":"571","author":"Alfei","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2020.10.002_bib0240","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/hep.28309","article-title":"Persistent hepatitis C viral replication despite priming of functional CD8+ T cells by combined therapy with a vaccine and a direct-acting antiviral","volume":"63","author":"Callendret","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2020.10.002_bib0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003422","article-title":"Galectin-9 and IL-21 mediate cross-regulation between Th17 and Treg cells during acute hepatitis C","volume":"9","author":"Kared","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2020.10.002_bib0250","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3389\/fimmu.2019.00606","article-title":"The transcription factor T-bet is required for optimal type I follicular helper T cell maintenance during acute viral infection","volume":"10","author":"Wang","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2020.10.002_bib0255","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1128\/JVI.03574-13","article-title":"Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses","volume":"88","author":"Chmielewska","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.10.002_bib0260","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/jvh.12465","article-title":"Memory re-differentiation and reduced lymphocyte activation in chronic HCV-infected patients receiving direct-acting antivirals","volume":"22","author":"Burchill","year":"2015","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.coviro.2020.10.002_bib0265","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1053\/j.gastro.2011.07.004","article-title":"Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection","volume":"141","author":"Raziorrouh","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coviro.2020.10.002_bib0270","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1126\/science.1088774","article-title":"HCV persistence and immune evasion in the absence of memory T cell help","volume":"302","author":"Grakoui","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.coviro.2020.10.002_bib0275","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1053\/j.gastro.2014.07.005","article-title":"Signatures of protective memory immune responses during hepatitis C virus reinfection","volume":"147","author":"Abdel-Hakeem","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coviro.2020.10.002_bib0280","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.4049\/jimmunol.1701364","article-title":"Memory T cell proliferation before hepatitis C virus therapy predicts antiviral immune responses and treatment success","volume":"200","author":"Mendez-Lagares","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2020.10.002_bib0285","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/hep.21319","article-title":"CD4+ immune escape and subsequent T-cell failure following chimpanzee immunization against hepatitis C virus","volume":"44","author":"Puig","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2020.10.002_bib0290","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1053\/j.gastro.2015.11.005","article-title":"Virus-specific CD4+ T cells have functional and phenotypic characteristics of follicular T-helper cells in patients with acute and chronic HCV infections","volume":"150","author":"Raziorrouh","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coviro.2020.10.002_bib0295","doi-asserted-by":"crossref","first-page":"10090","DOI":"10.1038\/s41598-019-46533-w","article-title":"Circulating CXCR3(+) Tfh cells positively correlate with neutralizing antibody responses in HCV-infected patients","volume":"9","author":"Zhang","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.coviro.2020.10.002_sbref0300","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1172\/JCI129642","article-title":"Follicular T helper cells shape the HCV-specific CD4+ T cell repertoire after virus elimination","volume":"130","author":"Smits","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coviro.2020.10.002_bib0305","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.dld.2015.06.014","article-title":"Role of regulatory T-cells during hepatitis C infection: from the acute phase to post-transplantation recurrence","volume":"47","author":"Barjon","year":"2015","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.coviro.2020.10.002_bib0310","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.jhep.2016.12.019","article-title":"Increased peripheral CD4(+) regulatory T cells persist after successful direct-acting antiviral treatment of chronic hepatitis C","volume":"66","author":"Langhans","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2020.10.002_sbref0315","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.chom.2018.10.012","article-title":"Broadly neutralizing antibody mediated clearance of human hepatitis C virus infection","volume":"24","author":"Kinchen","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2020.10.002_bib0320","doi-asserted-by":"crossref","first-page":"13300","DOI":"10.1038\/s41598-019-49454-w","article-title":"Clearance of hepatitis C virus is associated with early and potent but narrowly-directed, envelope-specific antibodies","volume":"9","author":"Walker","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.coviro.2020.10.002_bib0325","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1128\/JVI.02669-15","article-title":"Broad anti-hepatitis C virus (HCV) antibody responses are associated with improved clinical disease parameters in chronic HCV infection","volume":"90","author":"Swann","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.10.002_sbref0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007290","article-title":"Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance","volume":"14","author":"Rosenberg","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2020.10.002_bib0335","doi-asserted-by":"crossref","first-page":"9128","DOI":"10.1128\/JVI.01194-15","article-title":"Immunoglobulin with high-titer in vitro cross-neutralizing hepatitis C virus antibodies passively protects chimpanzees from homologous, but not heterologous, challenge","volume":"89","author":"Bukh","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.10.002_bib0340","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/infdis\/jir511","article-title":"Vaccine-induced cross-genotype reactive neutralizing antibodies against hepatitis C virus","volume":"204","author":"Meunier","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2020.10.002_bib0345","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jhep.2019.02.013","article-title":"Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance","volume":"71","author":"Merat","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2020.10.002_bib0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007772","article-title":"Broadly neutralizing antibodies from an individual that naturally cleared multiple hepatitis C virus infections uncover molecular determinants for E2 targeting and vaccine design","volume":"15","author":"Keck","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2020.10.002_bib0355","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/j.1440-1746.2011.06946.x","article-title":"Decreased anti-hepatitis C virus titer and associated factors in chronic hepatitis C patients after sustained virological response: a prospective study","volume":"27","author":"Kee","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.coviro.2020.10.002_bib0360","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.4049\/jimmunol.1600763","article-title":"Novel E2 glycoprotein tetramer detects hepatitis C virus-specific memory B cells","volume":"197","author":"Boisvert","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.coviro.2020.10.002_bib0365","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofx264","article-title":"Direct-acting antivirals improve access to care and cure for patients with HIV and chronic HCV infection","volume":"5","author":"Collins","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.coviro.2020.10.002_bib0370","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/cid\/ciw073","article-title":"Prevalence of diagnosed and undiagnosed hepatitis C in a midwestern urban emergency department","volume":"62","author":"Lyons","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2020.10.002_bib0375","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.3389\/fimmu.2018.01480","article-title":"Hepatitis C vaccines, antibodies, and T cells","volume":"9","author":"Shoukry","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2020.10.002_bib0380","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009185","article-title":"A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory","volume":"6","author":"Swadling","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coviro.2020.10.002_bib0385","article-title":"Highly-immunogenic virally-vectored T-cell vaccines cannot overcome subversion of the T-cell response by HCV during chronic infection","volume":"4","author":"Swadling","year":"2016","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.coviro.2020.10.002_sbref0390","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1053\/j.gastro.2019.11.282","article-title":"Antibody responses to immunization with HCV envelope glycoproteins as a baseline for B-cell-based vaccine development","volume":"158","author":"Chen","year":"2020","journal-title":"Gastroenterology"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625720300997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625720300997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:04:07Z","timestamp":1761818647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625720300997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":78,"alternative-id":["S1879625720300997"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2020.10.002","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune system control of hepatitis C virus infection","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2020.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}